276 related articles for article (PubMed ID: 21054245)
1. Large-scale production means for the manufacturing of lentiviral vectors.
Schweizer M; Merten OW
Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
[TBL] [Abstract][Full Text] [Related]
2. Production of lentiviral vectors.
Merten OW; Hebben M; Bovolenta C
Mol Ther Methods Clin Dev; 2016; 3():16017. PubMed ID: 27110581
[TBL] [Abstract][Full Text] [Related]
3. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
5. Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
Segura MM; Kamen A; Garnier A
Biotechnol Adv; 2006; 24(3):321-37. PubMed ID: 16448798
[TBL] [Abstract][Full Text] [Related]
6. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
[TBL] [Abstract][Full Text] [Related]
7. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.
Lesch HP; Laitinen A; Peixoto C; Vicente T; Makkonen KE; Laitinen L; Pikkarainen JT; Samaranayake H; Alves PM; Carrondo MJ; Ylä-Herttuala S; Airenne KJ
Gene Ther; 2011 Jun; 18(6):531-8. PubMed ID: 21248790
[TBL] [Abstract][Full Text] [Related]
8. Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application.
Merten OW; Charrier S; Laroudie N; Fauchille S; Dugué C; Jenny C; Audit M; Zanta-Boussif MA; Chautard H; Radrizzani M; Vallanti G; Naldini L; Noguiez-Hellin P; Galy A
Hum Gene Ther; 2011 Mar; 22(3):343-56. PubMed ID: 21043787
[TBL] [Abstract][Full Text] [Related]
9. Influence of mildly acidic pH conditions on the production of lentiviral and retroviral vectors.
Holic N; Seye AK; Majdoul S; Martin S; Merten OW; Galy A; Fenard D
Hum Gene Ther Clin Dev; 2014 Sep; 25(3):178-85. PubMed ID: 25073060
[TBL] [Abstract][Full Text] [Related]
10. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
11. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
12. Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy.
Coroadinha AS
Methods Mol Biol; 2022; 2521():297-315. PubMed ID: 35733005
[TBL] [Abstract][Full Text] [Related]
13. Gene delivery by lentivirus vectors.
Cockrell AS; Kafri T
Mol Biotechnol; 2007 Jul; 36(3):184-204. PubMed ID: 17873406
[TBL] [Abstract][Full Text] [Related]
14. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.
Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B
Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776
[TBL] [Abstract][Full Text] [Related]
15. Advances in Lentivirus Purification.
Moreira AS; Cavaco DG; Faria TQ; Alves PM; Carrondo MJT; Peixoto C
Biotechnol J; 2021 Jan; 16(1):e2000019. PubMed ID: 33089626
[TBL] [Abstract][Full Text] [Related]
16. Genome editing for scalable production of alloantigen-free lentiviral vectors for
Milani M; Annoni A; Bartolaccini S; Biffi M; Russo F; Di Tomaso T; Raimondi A; Lengler J; Holmes MC; Scheiflinger F; Lombardo A; Cantore A; Naldini L
EMBO Mol Med; 2017 Nov; 9(11):1558-1573. PubMed ID: 28835507
[TBL] [Abstract][Full Text] [Related]
17. Clinical grade lentiviral vector purification and quality control requirements.
Shi R; Jia S; Liu H; Nie H
J Sep Sci; 2022 Jun; 45(12):2093-2101. PubMed ID: 35247228
[TBL] [Abstract][Full Text] [Related]
18. Optimized production and concentration of lentiviral vectors containing large inserts.
al Yacoub N; Romanowska M; Haritonova N; Foerster J
J Gene Med; 2007 Jul; 9(7):579-84. PubMed ID: 17533614
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting.
Dasgupta A; Tinch S; Szczur K; Ernst R; Shryock N; Kaylor C; Lewis K; Day E; Truong T; Swaney W
Methods Mol Biol; 2020; 2086():27-60. PubMed ID: 31707666
[TBL] [Abstract][Full Text] [Related]
20. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection.
Kuroda H; Kutner RH; Bazan NG; Reiser J
J Virol Methods; 2009 May; 157(2):113-21. PubMed ID: 19114057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
